Barbara Sibbald
Extract
Mifepristone, the controversial “abortion pill,” may soon be available in the US, but the distribution rules may be so strict that they “hurt access.”. . . Mifepristone has been available to women in many European countries for more than a decade. More than 500 000 women worldwide have used it, with few complications reported. When taken with misoprostol, which has already been approved in Canada, mifepristone causes abortion – in essence a miscarriage – in 95% of women who are no more than 49 days pregnant.
Sibbald B. FDA considering restricted access to “abortion pill”. Can Med Assoc J. 2000 Sep 5;163(5):586.